PRECISION BIOSCIENCES INC - Common Stock, $0.000005 par value per share (DTIL)

Q: What does CUSIP 74019P207 represent in this 13F holders report?

CUSIP 74019P207 is the security identifier for DTIL - PRECISION BIOSCIENCES INC - Common Stock, $0.000005 par value per share used to aggregate holder disclosures.

Q: How many institutions held DTIL - PRECISION BIOSCIENCES INC - Common Stock, $0.000005 par value per share in Q2 2025?

51 institutional investors reported DTIL - PRECISION BIOSCIENCES INC - Common Stock, $0.000005 par value per share for Q2 2025. Use the holders table for investor-level position and value details.

CUSIP: 74019P207

Q2 2025 13F Holders as of 30 Jun 2025

Type / Class: Equity / Common Stock, $0.000005 par value per share
Shares outstanding: 25,804,443
Total 13F shares: 4,437,938
Share change: +651,590
Total reported value: $18,638,020
Price per share: $4.20
Number of holders: 51
Value change: +$2,152,791
Number of buys: 24
Number of sells: 15

Quarterly Holders Quick Answers

What is CUSIP 74019P207?
CUSIP 74019P207 identifies DTIL - PRECISION BIOSCIENCES INC - Common Stock, $0.000005 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2025
Previous quarter: Q1 2025

Recent filing periods for CUSIP 74019P207:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of DTIL - PRECISION BIOSCIENCES INC - Common Stock, $0.000005 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Readout Capital, LP	13D/G	Matthew Smith	9.4%	1,119,311	$4,980,934	+$829,645	30 Jun 2025	13D/G
NOVARTIS PHARMA AG	3/4/5 13D/G	10%+ Owner	3.7% from 13D/G	12,407,440	$4,590,753	—	15 Jun 2022	3/4/5 13D/G
Lynx1 Capital Management LP	13F	Company	3%	766,051	$3,654,063	—	31 Mar 2025	13F
Aquilo Capital Management, LLC	13F	Company	2.8%	726,149	$3,463,731	—	31 Mar 2025	13F
TANG CAPITAL MANAGEMENT LLC	13F	Company	2.6%	673,332	$3,211,794	—	31 Mar 2025	13F
HIGHBRIDGE CAPITAL MANAGEMENT LLC	13D/G	—	3.7%	406,250	$2,165,312	$0	31 Mar 2025	13D/G
Weinstein Benjamin	13D/G	—	5.2%	395,489	$2,107,956	$0	18 Mar 2025	13D/G
Derek Jantz	3/4/5	Chief Scientific Officer, Director	— mixed-class rows	4,079,565 mixed-class rows	$1,509,439	—	07 Jun 2022	3/4/5
VANGUARD GROUP INC	13F	Company	1.1%	281,083	$1,340,765	—	31 Mar 2025	13F
ACADIAN ASSET MANAGEMENT LLC	13F	Company	0.96%	248,620	$1,184,000	—	31 Mar 2025	13F
BOOTHBAY FUND MANAGEMENT, LLC	13F	Company	0.78%	200,000	$954,000	—	31 Mar 2025	13F
BALYASNY ASSET MANAGEMENT L.P.	13F	Company	0.74%	189,665	$904,705	—	31 Mar 2025	13F
Matthew R. Kane	3/4/5	President and CEO, Director	— mixed-class rows	2,026,513 mixed-class rows	$749,324	—	07 Jun 2021	3/4/5
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.32%	82,977	$395,800	—	31 Mar 2025	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.29%	73,687	$351,527	—	31 Mar 2025	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.25%	65,586	$312,845	—	31 Mar 2025	13F
Tejara Capital Ltd	13F	Company	0.23%	60,427	$288,237	—	31 Mar 2025	13F
UBS Group AG	13F	Company	0.22%	57,027	$272,019	—	31 Mar 2025	13F
BlackRock, Inc.	13F	Company	0.21%	54,819	$261,487	—	31 Mar 2025	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.21%	53,631	$255,820	—	31 Mar 2025	13F
Kevin Buehler	3/4/5	Director	— mixed-class rows	49,137 mixed-class rows	$234,961	+$21,116	25 Jun 2025	3/4/5
NORTHERN TRUST CORP	13F	Company	0.17%	43,027	$205,239	—	31 Mar 2025	13F
Moloney Securities Asset Management, LLC	13F	Company	0.17%	42,866	$204,471	—	31 Mar 2025	13F
ROYAL BANK OF CANADA	13F	Company	0.16%	40,000	$191,000	—	31 Mar 2025	13F
Shari Lisa Pire	3/4/5	Director	— mixed-class rows	35,028 mixed-class rows	$189,875	—	27 May 2025	3/4/5
COMMONWEALTH EQUITY SERVICES, LLC	13F	Company	0.14%	37,155	$177,000	—	31 Mar 2025	13F
Samuel C. Wadsworth	3/4/5	Director	— mixed-class rows	14,028 mixed-class rows	$161,277	—	04 Jun 2024	3/4/5
STATE STREET CORP	13F	Company	0.09%	22,042	$105,140	—	31 Mar 2025	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.05%	13,565	$64,705	—	31 Mar 2025	13F
MORGAN STANLEY	13F	Company	0.05%	12,271	$58,533	—	31 Mar 2025	13F
Bleichroeder LP	13F	Company	0.05%	12,077	$57,607	—	31 Mar 2025	13F
Alan List	3/4/5	Chief Medical Officer	— mixed-class rows	5,469 mixed-class rows	$56,440	—	01 May 2024	3/4/5
Miller Financial Services LLC	13F	Company	0.04%	10,000	$47,700	—	31 Mar 2025	13F
David S. Thomson	3/4/5	Chief Operating Officer	— mixed-class rows	130,768 mixed-class rows	$41,260	—	23 Jun 2021	3/4/5
Allworth Financial LP	13F	Company	0.02%	4,769	$26,230	—	31 Mar 2025	13F
NATIONAL BANK OF CANADA /FI/	13F	Company	0.02%	5,000	$23,600	—	31 Mar 2025	13F
Vivo Capital, LLC	13F	Company	0.02%	4,675	$22,301	—	31 Mar 2025	13F
Shane Barton	3/4/5	VP & Corporate Controller	— mixed-class rows	33,562 mixed-class rows	$12,418	—	07 Jun 2023	3/4/5
Fayaz Khazi	3/4/5	CEO of Elo Life Systems	— mixed-class rows	65,239 mixed-class rows	$8,880	—	07 Jun 2021	3/4/5
Newbridge Financial Services Group, Inc.	13F	Company	0.01%	1,600	$7,632	—	31 Mar 2025	13F
Tower Research Capital LLC (TRC)	13F	Company	0.01%	1,500	$7,155	—	31 Mar 2025	13F
CWM, LLC	13F	Company	0%	1,005	$5,000	—	31 Mar 2025	13F
SBI Securities Co., Ltd.	13F	Company	0%	470	$2,242	—	31 Mar 2025	13F
BARCLAYS PLC	13F	Company	0%	384	$1,832	—	31 Mar 2025	13F
RHUMBLINE ADVISERS	13F	Company	0%	275	$1,311	—	31 Mar 2025	13F
BANK OF AMERICA CORP /DE/	13F	Company	0%	132	$630	—	31 Mar 2025	13F
FMR LLC	13F	Company	0%	100	$477	—	31 Mar 2025	13F
SouthState Bank Corp	13F	Company	0%	95	$453	—	31 Mar 2025	13F
Zurcher Kantonalbank (Zurich Cantonalbank)	13F	Company	0%	69	$329	—	31 Mar 2025	13F
BNP PARIBAS FINANCIAL MARKETS	13F	Company	0%	55	$262	—	31 Mar 2025	13F

Institutional Holders of PRECISION BIOSCIENCES INC - Common Stock, $0.000005 par value per share (DTIL) as of Q2 2025

As of 30 Jun 2025, PRECISION BIOSCIENCES INC - Common Stock, $0.000005 par value per share (DTIL) was held by 51 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 4,437,938 shares. The largest 10 holders included Bleichroeder LP, Lynx1 Capital Management LP, TANG CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, ACADIAN ASSET MANAGEMENT LLC, BOOTHBAY FUND MANAGEMENT, LLC, Corient Private Wealth LLC, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, and BRIDGEWAY CAPITAL MANAGEMENT, LLC. This page lists 51 institutional shareholders reporting positions in this security for the Q2 2025 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2025 vs Q1 2025 Across Filers

Q1 2025 holders

Q2 2025 holders

Holder diff

Investor	Q1 2025 Shares	Q2 2025 Shares	Share Diff	Share Chg %	Q1 2025 Value $	Q2 2025 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.